Zhang Q - Search Results

1

OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer.

Sun X, Fu X, Xu S, Qiu P, Lv Z, Cui M, Zhang Q, Xu Y. Sun X, et al. Among authors: zhang q. Int Immunopharmacol. 2021 Dec;101(Pt B):108275. doi: 10.1016/j.intimp.2021.108275. Epub 2021 Oct 21. Int Immunopharmacol. 2021. PMID: 34688153

2

Repression of ESR1 transcription by MYOD potentiates letrozole-resistance in ERα-positive breast cancer cells.

Zhang Q, Liu XY, Li S, Zhao Z, Li J, Cui MK, Wang EH. Zhang Q, et al. Biochem Biophys Res Commun. 2017 Oct 21;492(3):425-433. doi: 10.1016/j.bbrc.2017.08.082. Epub 2017 Aug 24. Biochem Biophys Res Commun. 2017. PMID: 28842253

3

miR-1271 inhibits ERα expression and confers letrozole resistance in breast cancer.

Yu T, Yu HR, Sun JY, Zhao Z, Li S, Zhang XF, Liao ZX, Cui MK, Li J, Li C, Zhang Q. Yu T, et al. Among authors: zhang q, zhang xf. Oncotarget. 2017 Nov 9;8(63):107134-107148. doi: 10.18632/oncotarget.22359. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29291017 Free PMC article.

4

Upregulation of PITX2 Promotes Letrozole Resistance Via Transcriptional Activation of IFITM1 Signaling in Breast Cancer Cells.

Xu YY, Yu HR, Sun JY, Zhao Z, Li S, Zhang XF, Liao ZX, Cui MK, Li J, Li C, Zhang Q. Xu YY, et al. Among authors: zhang q, zhang xf. Cancer Res Treat. 2019 Apr;51(2):576-592. doi: 10.4143/crt.2018.100. Epub 2018 Jul 18. Cancer Res Treat. 2019. PMID: 30025446 Free PMC article.

5

Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy.

Li X, Wang M, Wang M, Yu X, Guo J, Sun T, Yao L, Zhang Q, Xu Y. Li X, et al. Among authors: zhang q. J Breast Cancer. 2019 Dec;22(4):497-521. doi: 10.4048/jbc.2019.22.e49. J Breast Cancer. 2019. PMID: 31897326 Free PMC article. Review.

6

Leptin-elicited PBX3 confers letrozole resistance in breast cancer.

Pang ZY, Wei YT, Shang MY, Li S, Li Y, Jin QX, Liao ZX, Cui MK, Liu XY, Zhang Q. Pang ZY, et al. Among authors: zhang q. Endocr Relat Cancer. 2021 Feb 1:ERC-20-0328.R2. doi: 10.1530/ERC-20-0328. Online ahead of print. Endocr Relat Cancer. 2021. PMID: 33608482

7

An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine.

Wang M, Pang Z, Wang Y, Cui M, Yao L, Li S, Wang M, Zheng Y, Sun X, Dong H, Zhang Q, Xu Y. Wang M, et al. Among authors: zhang q. Front Oncol. 2021 Apr 27;11:651809. doi: 10.3389/fonc.2021.651809. eCollection 2021. Front Oncol. 2021. PMID: 33987087 Free PMC article.

8

The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study.

Yao L, Pang Z, Wang M, Wang M, Sun X, Cui M, Zheng Y, Li X, Dong H, Zhang Q, Xu Y. Yao L, et al. Among authors: zhang q. Cancer Biol Med. 2021 Oct 12;19(5):755-67. doi: 10.20892/j.issn.2095-3941.2020.0800. Online ahead of print. Cancer Biol Med. 2021. PMID: 34633775 Free PMC article.

9

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy.

Tan S, Fu X, Xu S, Qiu P, Lv Z, Xu Y, Zhang Q. Tan S, et al. Among authors: zhang q. Pathol Oncol Res. 2021 Dec 20;27:1609972. doi: 10.3389/pore.2021.1609972. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34987312 Free PMC article.

10

SEZ6L2, regulated by USF1, accelerates the growth and metastasis of breast cancer.

Chen L, Han S, Li Y, Zheng Y, Zhang Q. Chen L, et al. Among authors: zhang q. Exp Cell Res. 2022 Aug 1;417(1):113194. doi: 10.1016/j.yexcr.2022.113194. Epub 2022 May 4. Exp Cell Res. 2022. PMID: 35523305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69,996 results

Search Page

Filters